| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 06/15/2022 | 323.28% | Roth Capital | → $8 | Reinstates | → Buy |
| 06/02/2022 | 138.1% | Cantor Fitzgerald | → $4.5 | Initiates Coverage On | → Overweight |
| 05/12/2022 | 270.37% | HC Wainwright & Co. | $8 → $7 | Maintains | Buy |
| 02/28/2022 | 323.28% | HC Wainwright & Co. | $10 → $8 | Maintains | Buy |
| 06/11/2021 | 217.46% | Roth Capital | $10 → $6 | Downgrades | Buy → Neutral |
| 06/11/2021 | 429.1% | HC Wainwright & Co. | $12 → $10 | Maintains | Buy |
| 05/07/2021 | 482.01% | Cantor Fitzgerald | $15 → $11 | Downgrades | Overweight → Neutral |
| 03/03/2021 | 693.65% | Cantor Fitzgerald | $4 → $15 | Maintains | Overweight |
| 02/09/2021 | 587.83% | Chardan Capital | $0.7 → $13 | Downgrades | Buy → Neutral |
| 02/04/2021 | 138.1% | HC Wainwright & Co. | → $4.5 | Upgrades | Neutral → Buy |
| 11/17/2020 | -47.09% | Roth Capital | → $1 | Initiates Coverage On | → Buy |
| 10/09/2020 | -47.09% | Cantor Fitzgerald | → $1 | Initiates Coverage On | → Overweight |
| 06/03/2020 | -62.96% | Chardan Capital | $2 → $0.7 | Maintains | Buy |
| 06/01/2020 | — | HC Wainwright & Co. | Downgrades | Buy → Neutral | |
| 12/20/2019 | — | HC Wainwright & Co. | Initiates Coverage On | → Buy | |
| 11/27/2019 | 5.82% | Chardan Capital | → $2 | Initiates Coverage On | → Buy |
Ocugen Questions & Answers
The latest price target for Ocugen (NASDAQ: OCGN) was reported by Roth Capital on June 15, 2022. The analyst firm set a price target for $8.00 expecting OCGN to rise to within 12 months (a possible 323.28% upside). 4 analyst firms have reported ratings in the last year.
The latest analyst rating for Ocugen (NASDAQ: OCGN) was provided by Roth Capital, and Ocugen their buy rating.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Ocugen, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Ocugen was filed on June 15, 2022 so you should expect the next rating to be made available sometime around June 15, 2023.
While ratings are subjective and will change, the latest Ocugen (OCGN) rating was a with a price target of $0.00 to $8.00. The current price Ocugen (OCGN) is trading at is $1.89, which is within the analyst's predicted range.